Genor Biopharma Holdings Limited(DE:67N0)
€0.17+0.00 (+1.18%)
DE:67N0
Genor Biopharma Holdings Limited earnings date
€0.17
At close:+0.00 (+1.18%)
Genor Biopharma Holdings Limited (67N0) Q2 2022 Earnings Report
0 Followers
DE:67N0 Q2 2022 EPS Results
- Actual EPS
- -EUR 0.11
- Consensus EPS
- -EUR 0.94
- Beat/Miss
- Beat by +EUR 0.83
- One Year Ago EPS
- -EUR 0.11
DE:67N0 Q2 2022 Revenue Results
- Actual Revenue
- EUR 400.18K
- Expected Revenue
- EUR 49.99M
- Beat/Miss
- Missed by -EUR 49.59M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/30/2022
- Time
- TBA
- Conference Call
- Tuesday, August 30, 2022
DE:67N0 Upcoming Earnings
Genor Biopharma Holdings Limited's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:67N0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | 0.04 | ― | ― |
| Aug 28, 2026 | 2026 (Q2) | ―-0.00 | -0.01 | 66.07% (+0.01) | |
| Mar 27, 2026 | 2025 (Q4) | ―0.04 | 0.02 | 140.38% (+0.02) | |
| Aug 29, 2025 | 2025 (Q2) | ―-0.01 | -0.03 | 55.20% (+0.02) | |
| Mar 30, 2025 | 2024 (Q4) | ―0.02 | -0.1 | 118.18% (+0.11) | |
| Aug 28, 2024 | 2024 (Q2) | ―-0.03 | -0.07 | 53.70% (+0.04) | |
| Mar 27, 2024 | 2023 (Q4) | -0.06-0.10 | -0.07 | -34.06% (-0.02) | |
| Aug 30, 2023 | 2023 (Q2) | -0.07-0.07 | -0.11 | 34.15% (+0.04) | |
| Mar 30, 2023 | 2022 (Q4) | -0.06-0.08 | -0.12 | 31.91% (+0.04) | |
| Aug 30, 2022 | 2022 (Q2) | -0.94-0.11 | -0.11 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
